{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T22:40:08Z","timestamp":1737067208315,"version":"3.33.0"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2001,8,1]],"date-time":"2001-08-01T00:00:00Z","timestamp":996624000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Gastro"],"published-print":{"date-parts":[[2001,8]]},"DOI":"10.1007\/s11938-001-0060-0","type":"journal-article","created":{"date-parts":[[2007,6,3]],"date-time":"2007-06-03T17:46:02Z","timestamp":1180892762000},"page":"339-349","source":"Crossref","is-referenced-by-count":0,"title":["Augmented visceral perception"],"prefix":"10.1007","volume":"4","author":[{"given":"William L.","family":"Hasler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"60_CR1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1007\/BF01395503","volume":"25","author":"WE Whitehead","year":"1980","unstructured":"Whitehead WE, Engel BT, Schuster MM: Irritable bowel syndrome: physiological and psychological differences between diarrhea-predominant and constipation-predominant patients. Dig Dis Sci 1980, 25:404\u2013413.","journal-title":"Dig Dis Sci"},{"key":"60_CR2","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0016-5085(91)90726-2","volume":"101","author":"F Mearin","year":"1991","unstructured":"Mearin F, Cucala M, Azpiroz F, Malagelada J-R: The origin of symptoms on the brain-gut axis in functional dyspepsia. Gastroenterology 1991, 101:999\u20131006.","journal-title":"Gastroenterology"},{"key":"60_CR3","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S0140-6736(80)91885-1","volume":"2","author":"ET Swarbrick","year":"1980","unstructured":"Swarbrick ET, Hegarty JE, Bat L, et al.: Site of pain from the irritable bowel. Lancet 1980, 2:443\u2013446.","journal-title":"Lancet"},{"key":"60_CR4","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1016\/S0016-5085(98)70012-5","volume":"115","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al.: Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1586\u20131587.","journal-title":"Gastroenterology"},{"key":"60_CR5","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/BF02213124","volume":"41","author":"OH Gilja","year":"1996","unstructured":"Gilja OH, Hausken T, Wilhelmsen I, Berstad A: Impaired accommodation of proximal stomach to a meal in functional dyspepsia. Dig Dis Sci 1996, 41:689\u2013696.","journal-title":"Dig Dis Sci"},{"key":"60_CR6","first-page":"G1232","volume":"114","author":"J Tack","year":"1998","unstructured":"Tack J, Piessevaux H, Coulie B, et al.: Role of visceral hypersensitivity in patients with functional dyspepsia [abstract]. Gastroenterology 1998, 114:G1232.","journal-title":"Gastroenterology"},{"key":"60_CR7","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/00004836-199806000-00022","volume":"26","author":"JS Finney","year":"1998","unstructured":"Finney JS, Kinnersley N, Hughes M, et al.: Meta-analysis of antisecretory and gastrokinetic compounds in functional dyspepsia. J Clin Gastroenterol 1998, 26:312\u2013320. This article combines the results from several placebocontrolled trials of acid-suppressing and prokinetic medications in functional dyspepsia, and by using meta-analysis elicits important comparisons of the different drug classes in this prevalent condition.","journal-title":"J Clin Gastroenterol"},{"key":"60_CR8","first-page":"G0819","volume":"116","author":"G Holtmann","year":"1999","unstructured":"Holtmann G, Karaus M, Gschossmann J, et al.: Simethicone and cisapride in functional dyspepsia: a double-blind randomized trial [abstract]. Gastroenterology 1999, 116:G0819.","journal-title":"Gastroenterology"},{"key":"60_CR9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1572-0241.1998.00160.x","volume":"93","author":"H Mertz","year":"1998","unstructured":"Mertz H, Fass R, Kodner A, et al.: Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998, 93:160\u2013165.","journal-title":"Am J Gastroenterol"},{"key":"60_CR10","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1007\/BF02087560","volume":"39","author":"B Fraitag","year":"1994","unstructured":"Fraitag B, Homerin M, Hecketsweiler P: Double-blind dose-response multicenter comparison of fedotozine and placebo in treatment of nonulcer dyspepsia. Dig Dis Sci 1994, 39:1072\u20131077.","journal-title":"Dig Dis Sci"},{"key":"60_CR11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gut.41.5.717","volume":"41","author":"NW Read","year":"1997","unstructured":"Read NW, Abitbol JL, Bardhan KD, et al.: Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut 1997, 41:717\u2013718.","journal-title":"Gut"},{"key":"60_CR12","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1365-2036.1996.30172000.x","volume":"10","author":"DG Maxton","year":"1996","unstructured":"Maxton DG, Morris J, Whorwell PJ: Selective 5-hydroxytryptamine antagonism: a role in irritable bowel syndrome and functional dyspepsia? Aliment Pharmacol Ther 1996, 10:595\u2013599.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR13","first-page":"G0652","volume":"116","author":"P Ducrotte","year":"1999","unstructured":"Ducrotte P, Maillot C, Leroi AM, et al.: Octreotide in refractory functional epigastric pain with nutritional impairment: a pilot trial [abstract]. Gastroenterology 1999, 116:G0652.","journal-title":"Gastroenterology"},{"key":"60_CR14","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/0016-5085(94)90536-3","volume":"107","author":"B Coffin","year":"1994","unstructured":"Coffin B, Azpiroz F, Guarner F, Malagelada JR: Selective gastric hypersensitivity and reflex hyporeactivity in functional dyspepsia. Gastroenterology 1994, 107:1345\u20131351.","journal-title":"Gastroenterology"},{"key":"60_CR15","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2036.1995.tb00364.x","volume":"9","author":"JE Kellow","year":"1995","unstructured":"Kellow JE, Cowan H, Shuter B, et al.: Efficacy of cisapride therapy in functional dyspepsia. Aliment Pharmacol Ther 1995, 9:153\u2013160.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR16","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1046\/j.1365-2036.1998.00366.x","volume":"12","author":"J Tack","year":"1998","unstructured":"Tack J, Broeckaert D, Coulie B, Janssens J: The influence of cisapride on gastric tone and the perception of gastric distention. Aliment Pharmacol Ther 1998, 12:761\u2013766.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR17","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1023\/A:1018839122354","volume":"42","author":"OH Gilja","year":"1997","unstructured":"Gilja OH, Hausken T, Bang CJ, Berstad A: Effect of glyceryl trinitrate on gastric accommodation and symptoms in functional dyspepsia. Dig Dis Sci 1997, 42:2124\u20132131.","journal-title":"Dig Dis Sci"},{"key":"60_CR18","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0016-5085(99)70179-4","volume":"116","author":"M Thumshirm","year":"1999","unstructured":"Thumshirm M, Camilleri M, Choi MG, Zinsmeister AR: Modulation of gastric sensory and motor functions by nitrergic and alpha2-adrenergic agents in humans. Gastroenterology 1999, 116:573\u2013585.","journal-title":"Gastroenterology"},{"key":"60_CR19","first-page":"G373","volume":"276","author":"B Coulie","year":"1999","unstructured":"Coulie B, Tack J, Sifrim D, et al.: Role of nitric oxide in fasting gastric tone and in 5-HT1 receptormediated relaxation of gastric fundus. Am J Physiol 1999, 276:G373-G377.","journal-title":"Am J Physiol"},{"key":"60_CR20","first-page":"G1423","volume":"116","author":"J Tack","year":"1999","unstructured":"Tack J, Piessevaux H, Coulie B, et al.: A placebocontrolled trial of buspirone, a fundus-relaxing drug, in functional dyspepsia: effect on symptoms and gastric sensory and motor function [abstract]. Gastroenterology 1999, 116:G1423.","journal-title":"Gastroenterology"},{"key":"60_CR21","first-page":"G1419","volume":"116","author":"J Tack","year":"1999","unstructured":"Tack J, Piessevaux H, Coulie B, Janssens J: Influence of a fundus-relaxing drug on meal-related symptoms in dyspeptic patients with hypersensitivity to gastric distention [abstract]. Gastroenterology 1999, 116:G1419.","journal-title":"Gastroenterology"},{"key":"60_CR22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/0016-5085(95)90267-8","volume":"109","author":"H Mertz","year":"1995","unstructured":"Mertz H, Naliboff B, Munakata J, et al.: Altered rectal perception is a biological marker of patients with irritable bowel syndrome. Gastroenterology 1995, 109:40\u201352.","journal-title":"Gastroenterology"},{"key":"60_CR23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/gut.31.4.458","volume":"31","author":"A Prior","year":"1990","unstructured":"Prior A, Maxton DG, Whorwell PJ: Anorectal manometry in irritable bowel syndrome: differences between diarrhoea and constipation predominant patients. Gut 1990, 31:458\u2013462.","journal-title":"Gut"},{"key":"60_CR24","first-page":"A782","volume":"112","author":"E Marchand","year":"1997","unstructured":"Marchand E, Bradette M, Pare P, Douville P: Dietary fibers increase the threshold for discomfort and pain perception during colonic distention in IBS patients [abstract]. Gastroenterology 1997, 112:A782.","journal-title":"Gastroenterology"},{"key":"60_CR25","doi-asserted-by":"crossref","first-page":"871","DOI":"10.3109\/00365528209181108","volume":"17","author":"J Myren","year":"1982","unstructured":"Myren J, Groth H, Larssen S-E, Larsen S: The effect of trimipramine in patients with the irritable bowel syndrome: a double-blind study. Scand J Gastroenterol 1982, 17:871\u2013875.","journal-title":"Scand J Gastroenterol"},{"key":"60_CR26","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1080\/00365521.1984.12005817","volume":"19","author":"J Myren","year":"1984","unstructured":"Myren J, Lovland B, Larssen S-E, Larsen S: A doubleblind study of the effect of trimipramine in patients with the irritable bowel syndrome. Scand J Gastroenterol 1984, 19:835\u2013843.","journal-title":"Scand J Gastroenterol"},{"key":"60_CR27","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/S0033-3182(78)70930-8","volume":"19","author":"JD Heefner","year":"1978","unstructured":"Heefner JD, Wilder RM, Wilson ID: Irritable colon and depression. Psychosomatics 1978, 19:540\u2013547.","journal-title":"Psychosomatics"},{"key":"60_CR28","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/BF01297051","volume":"32","author":"DS Greenbaum","year":"1987","unstructured":"Greenbaum DS, Mayle JE, Vanegeren LE, et al.: Effects of desipramine on irritable bowel syndrome compared with atropine and placebo. Dig Dis Sci 1987, 32:257\u2013266.","journal-title":"Dig Dis Sci"},{"key":"60_CR29","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-0447.1982.tb00912.x","volume":"66","author":"MJ Lancaster-Smith","year":"1982","unstructured":"Lancaster-Smith MJ, Prout BJ, Pinto T, et al.: Influence of drug treatment on the irritable bowel syndrome and its interaction with psychoneurotic morbidity. Acta Psychiatr Scand 1982, 66:33\u201341.","journal-title":"Acta Psychiatr Scand"},{"key":"60_CR30","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.281.6251.1317","volume":"281","author":"JA Ritchie","year":"1980","unstructured":"Ritchie JA, Truelove SC: Comparison of various treatments for irritable bowel syndrome. BMJ 1980, 281:1317\u20131319.","journal-title":"BMJ"},{"key":"60_CR31","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/gut.42.6.807","volume":"42","author":"PL Peghini","year":"1998","unstructured":"Peghini PL, Katz PO, Castell DO: Imipramine decreases oesophageal pain perception in human male volunteers. Gut 1998, 42:807\u2013813.","journal-title":"Gut"},{"key":"60_CR32","first-page":"G460","volume":"275","author":"AB Gorelick","year":"1998","unstructured":"Gorelick AB, Koshy SS, Hooper FG, et al.: Differential effects of amitriptyline on perception of somatic and visceral stimulation in healthy humans. Am J Physiol 1998, 275:G460-G466.","journal-title":"Am J Physiol"},{"key":"60_CR33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1159\/000201377","volume":"57","author":"PA Goldberg","year":"1996","unstructured":"Goldberg PA, Kamm MA, Setti-Carraro P, et al.: Modification of visceral sensitivity and pain in irritable bowel syndrome by 5-HT3 antagonism (ondansetron). Digestion 1996, 57:478\u2013483.","journal-title":"Digestion"},{"key":"60_CR34","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2036.1993.tb00087.x","volume":"7","author":"A Prior","year":"1993","unstructured":"Prior A, Read NW: Reduction of rectal sensitivity and post-prandial motility by granisetron, a 5-HT3-receptor antagonist, in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1993, 7:175\u2013180.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR35","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0016-5085(99)70226-X","volume":"116","author":"M Delvaux","year":"1999","unstructured":"Delvaux M, Louvel D, Lagier E, et al.: The kappa agonist fedotozine relieves hypersensitivity to colonic distention in patients with irritable bowel syndrome. Gastroenterology 1999, 116:38\u201345.","journal-title":"Gastroenterology"},{"key":"60_CR36","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1007\/BF02209014","volume":"40","author":"M Dapoigny","year":"1995","unstructured":"Dapoigny M, Abitbol JL, Fraitag B: Efficacy of peripheral kappa agonist fedotozine versus placebo in treatment of irritable bowel syndrome. A multicenter dose-response study. Dig Dis Sci 1995, 40:2244\u20132249.","journal-title":"Dig Dis Sci"},{"issue":"suppl 2","key":"60_CR37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.1365-2036.1999.00010.x","volume":"13","author":"AW Mangel","year":"1999","unstructured":"Mangel AW, Northcutt AR: Review article: the safety and efficacy of alosetron, a 5-HT3 receptor antagonist, in female irritable bowel syndrome patients. Aliment Pharmacol Ther 1999, 13(suppl 2):77\u201382.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR38","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1046\/j.1365-2036.1998.00375.x","volume":"12","author":"M Delvaux","year":"1998","unstructured":"Delvaux M, Louvel D, Mamet JP, et al.: Effect of alosetron on responses to colonic distention in patients with irritable bowel syndrome. Aliment Pharmacol Ther 1998, 12:849\u2013855.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR39","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/0016-5085(93)90347-F","volume":"104","author":"WL Hasler","year":"1993","unstructured":"Hasler WL, Soudah HC, Owyang C: A somatostatin analogue inhibits afferent pathways mediating perception of rectal distention. Gastroenterology 1993, 104:1390\u20131397.","journal-title":"Gastroenterology"},{"key":"60_CR40","first-page":"1206","volume":"268","author":"WL Hasler","year":"1994","unstructured":"Hasler WL, Soudah HC, Owyang C: Somatostatin analog inhibits afferent response to rectal distention in diarrhea-predominant irritable bowel patients. J Pharmacol Exp Ther 1994, 268:1206\u20131211.","journal-title":"J Pharmacol Exp Ther"},{"key":"60_CR41","first-page":"G4497","volume":"116","author":"A Malcolm","year":"1999","unstructured":"Malcolm A, Kellow JE, Camilleri M.: Clonidine alters rectal motor and sensory function in irritable bowel syndrome [abstract]. Gastroenterology 1999, 116:G4497.","journal-title":"Gastroenterology"},{"key":"60_CR42","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1136\/gut.39.5.741","volume":"39","author":"D Louvel","year":"1996","unstructured":"Louvel D, Delvaux M, Felez A, et al.: Oxytocin increases thresholds of colonic visceral perception in patients with irritable bowel syndrome. Gut 1996, 39:741\u2013747.","journal-title":"Gut"},{"key":"60_CR43","first-page":"G3046","volume":"114","author":"B Coulie","year":"1998","unstructured":"Coulie B, Tack J, Vos R, Janssens J: Influence of the 5-HT1A agonist buspirone on rectal tone and on the perception of rectal distention in man [abstract]. Gastroenterology 1998, 114:G3046.","journal-title":"Gastroenterology"},{"key":"60_CR44","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1046\/j.1365-2036.1998.00410.x","volume":"12","author":"NJ Talley","year":"1998","unstructured":"Talley NJ, Meineche-Schmidt V, Pare P, et al.: Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials. Aliment Pharmacol Ther 1998, 12:1055\u20131065.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR45","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/gast.1996.v110.pm8536890","volume":"110","author":"MD Silverstein","year":"1996","unstructured":"Silverstein MD, Petterson T, Talley NJ: Initial endoscopy or empirical therapy with or without testing for Helicobacter pylori for dyspepsia: a decision analysis. Gastroenterology 1996, 110:72\u201383.","journal-title":"Gastroenterology"},{"key":"60_CR46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.7326\/0003-4819-123-4-199508150-00003","volume":"123","author":"AM Fendrick","year":"1995","unstructured":"Fendrick AM, Chernew ME, Hirth RA, Bloom BS: Alternative management strategies for patients with suspected peptic ulcer disease. Ann Intern Med 1995, 123:260\u2013268.","journal-title":"Ann Intern Med"},{"key":"60_CR47","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0016-5085(98)70542-6","volume":"114","author":"NJ Talley","year":"1998","unstructured":"TalleyNJ, Silverstein MD, Agreus L, et al.: AGA technical review: evaluation of dyspepsia. Gastroenterology 1998, 114:582\u2013595. This article provides an American Gastroenterological Association-sponsored review of the current recommended diagnostic and therapeutic interventions for the patient with uninvestigated dyspepsia and thus represents the stateof-the-art management of this symptom complex.","journal-title":"Gastroenterology"},{"key":"60_CR48","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/00365528708991874","volume":"22","author":"W Rosch","year":"1987","unstructured":"Rosch W: Cisapride in non-ulcer dyspepsia. Results of a placebo-controlled trial. Scand J Gastroenterol 1987, 22:161\u2013164.","journal-title":"Scand J Gastroenterol"},{"key":"60_CR49","first-page":"261","volume":"42","author":"C Goethals","year":"1987","unstructured":"Goethals C, Van de Mierop L: Cisapride in the treatment of chronic functional dyspepsia. Results of a double-blind, placebo-controlled, crossover study. Curr Ther Res 1987, 42:261\u2013266.","journal-title":"Curr Ther Res"},{"key":"60_CR50","first-page":"814","volume":"42","author":"R Hannon","year":"1987","unstructured":"Hannon R: Efficacy of cisapride in patients with non-ulcer dyspepsia. A placebo-controlled study. Curr Ther Res 1987, 42:814\u2013820.","journal-title":"Curr Ther Res"},{"key":"60_CR51","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000198352","volume":"19","author":"L Mierop Van de","year":"1979","unstructured":"Van de Mierop L, Rutgeerts L, Van den Langenbergh B, Staessen A: Oral domperidone in chronic postprandial dyspepsia. A double-blind placebo-controlled evaluation. Digestion 1979, 19:244\u2013250.","journal-title":"Digestion"},{"key":"60_CR52","first-page":"695","volume":"23","author":"W Ganse Van","year":"1978","unstructured":"Van Ganse W, Van Damme L, Vande Mierop L, et al.: Chronic dyspepsia: double-blind treatment with domperidone (R33812) or a placebo. A multicentre therapeutic evaluation. Curr Ther Res 1978, 23:695\u2013701.","journal-title":"Curr Ther Res"},{"key":"60_CR53","first-page":"G0630","volume":"114","author":"S Howell","year":"1998","unstructured":"Howell S, Talley NJ, Cairns D: Do dyspepsia subgroups predict response to treatment in functional dyspepsia [abstract]? Gastroenterology 1998, 114:G0630.","journal-title":"Gastroenterology"},{"key":"60_CR54","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1056\/NEJM199812243392602","volume":"339","author":"AL Blum","year":"1998","unstructured":"Blum AL, Talley NJ, O\u2019Morain C, et al.: Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998, 339:1875\u20131881.","journal-title":"N Engl J Med"},{"key":"60_CR55","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1056\/NEJM199812243392601","volume":"339","author":"K McColl","year":"1998","unstructured":"McColl K, Murray L, El-Omar E, et al.: Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998, 339:1869\u20131874.","journal-title":"N Engl J Med"},{"key":"60_CR56","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1023\/A:1026628000491","volume":"43","author":"L Marzio","year":"1998","unstructured":"Marzio L, Falcucci M, Grossi L, et al.: Proximal and distal gastric distension in normal subjects and H. pylori-positive and -negative dyspeptic patients and correlation with symptoms. Dig Dis Sci 1998, 43:2757\u20132763.","journal-title":"Dig Dis Sci"},{"key":"60_CR57","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1136\/gut.44.1.55","volume":"44","author":"M Thumshirm","year":"1999","unstructured":"Thumshirm M, Camilleri M, Saslow SB, et al.: Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999, 44:55\u201364.","journal-title":"Gut"},{"key":"60_CR58","first-page":"G0275","volume":"116","author":"G Holtmann","year":"1999","unstructured":"Holtmann G, Madisch A, Hotz J, et al.: A double-blind, randomized, placebo-controlled trial on the effects of a herbal preparation in patients with functional dyspepsia [abstract]. Gastroenterology 1999, 116:G0275.","journal-title":"Gastroenterology"},{"key":"60_CR59","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1053\/gast.1999.0029900388","volume":"117","author":"TJ Ness","year":"1999","unstructured":"Ness TJ: Kappa opioid receptor agonists differentially inhibit two classes of rat spinal neurons excited by colorectal distention. Gastroenterology 1999, 117:388\u2013394.","journal-title":"Gastroenterology"},{"key":"60_CR60","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2982.1995.tb00223.x","volume":"7","author":"H Mertz","year":"1995","unstructured":"Mertz H, Walsh JH, Sytnik B, Mayer EA: The effect of octreotide on human gastric compliance and sensory perception. Neurogastroenterol Motil 1995, 7:175\u2013185.","journal-title":"Neurogastroenterol Motil"},{"key":"60_CR61","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1016\/S0022-3565(24)37504-4","volume":"285","author":"MJ Field","year":"1998","unstructured":"Field MJ, McCleary S, Boden P, et al.: Involvement of the central tachykinin NK1 receptor during maintenance of mechanical hypersensitivity induced by diabetes in the rat. J Pharmacol Exp Ther 1998, 285:1226\u20131232.","journal-title":"J Pharmacol Exp Ther"},{"key":"60_CR62","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/gut.30.5.634","volume":"30","author":"J Rogers","year":"1989","unstructured":"Rogers J, Henry MM, Misiewicz JJ: Increased segmental activity and intraluminal pressures in the sigmoid colon of patients with the irritable bowel syndrome. Gut 1989, 30:634\u2013641.","journal-title":"Gut"},{"key":"60_CR63","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1365-2036.1994.tb00322.x","volume":"8","author":"T Poynard","year":"1994","unstructured":"PoynardT, Naveau S, Mory B, Chaput JC: Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome. Aliment Pharmacol Ther 1994, 8:499\u2013510. Most single-institution publications show little or no benefit of antispasmodic agents in the control of pain in patients with IBS. This article, using meta-analysis, demonstrates a therapeutic role for this class of drugs.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR64","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/0016-5085(79)90162-8","volume":"77","author":"WJ Snape","year":"1979","unstructured":"Snape WJ, Wright SH, Battle WM, Cohen S: The gastrocolic response: evidence for a neural mechanism. Gastroenterology 1979, 77:1235\u20131240.","journal-title":"Gastroenterology"},{"key":"60_CR65","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/j.1365-2036.1994.tb00308.x","volume":"8","author":"RE Clouse","year":"1994","unstructured":"ClouseRE, Lustman PJ, Geisman RA, Alpers DH: Antidepressant therapy in 138 patients with irritable bowel syndrome: a five-year clinical experience. Aliment Pharmacol Ther 1994, 8:409\u2013416. Although uncontrolled, this article reports on the impressive benefits of both tricyclic antidepressants and SSRIs in individuals with IBS.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR66","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0304-3959(98)00031-1","volume":"76","author":"X Su","year":"1998","unstructured":"Su X, Gebhart GF: Effects of tricyclic antidepressants on mechanosensitive pelvic nerve afferent fibers innervating the rat colon. Pain 1998, 76:105\u2013114.","journal-title":"Pain"},{"key":"60_CR67","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1023\/A:1018888631286","volume":"43","author":"JR Mathias","year":"1998","unstructured":"Mathias JR, Clench MH, Abell TL, et al.: Effect of leuprolide acetate in treatment of abdominal pain and nausea in premenopausal women with functional bowel disease: a double-blind, placebo-controlled, randomized study. Dig Dis Sci 1998, 43:1347\u20131355.","journal-title":"Dig Dis Sci"},{"key":"60_CR68","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/BF02093778","volume":"39","author":"JR Mathias","year":"1994","unstructured":"Mathias JR, Clench MH, Reeves-Darby VG, et al.: Effect of leuprolide acetate in patients with moderate to severe functional bowel disease. Double-blind, placebo-controlled study. Dig Dis Sci 1994, 39:1155\u20131162.","journal-title":"Dig Dis Sci"},{"key":"60_CR69","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1007\/BF01299872","volume":"37","author":"JR Mathias","year":"1992","unstructured":"Mathias JR, Baskin GS, Reeves-Darby VG, et al.: Chronic intestinal pseudoobstruction in a patients with heart-lung transplant. Therapeutic effect of leuprolide acetate. Dig Dis Sci 1992, 37:1761\u20131768.","journal-title":"Dig Dis Sci"},{"issue":"suppl 2","key":"60_CR70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1365-2036.1999.00008.x","volume":"13","author":"EA Mayer","year":"1999","unstructured":"Mayer EA, Naliboff B, Lee O, et al.: Review article: gender-related differences in functional gastrointestinal disorders. Aliment Pharmacol Ther 1999, 13(suppl 2):65\u201369.","journal-title":"Aliment Pharmacol Ther"},{"key":"60_CR71","first-page":"277","volume":"91","author":"NJ Talley","year":"1996","unstructured":"Talley NJ, Owen BK, Boyce P, Paterson K: Psychological treatments for irritable bowel syndrome: a critique of controlled treatment trials. Am J Gastroenterol 1996, 91:277\u2013283.","journal-title":"Am J Gastroenterol"},{"key":"60_CR72","first-page":"A727","volume":"110","author":"M O\u2019Sullivan","year":"1996","unstructured":"O\u2019Sullivan M, O\u2019Morain C: Probiotics in the treatment of irritable bowel syndrome\u2014a randomized double blind placebo controlled crossover study [abstract]. Gastroenterology 1996, 110:A727.","journal-title":"Gastroenterology"},{"key":"60_CR73","first-page":"A677","volume":"110","author":"O Hentschel","year":"1996","unstructured":"Hentschel O, Bauer J, Kohnen R, et al.: Complementary medicine in irritable bowel syndrome: a randomized double blind, placebo-controlled trial [abstract]. Gastroenterology 1996, 110:A677.","journal-title":"Gastroenterology"},{"key":"60_CR74","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1001\/jama.280.18.1585","volume":"280","author":"A Bensoussan","year":"1998","unstructured":"Bensoussan A, Talley NJ, Hing M, et al.: Treatment of irritable bowel syndrome with Chinese herbal medicine\u2014a randomized controlled trial. JAMA 1998, 280:1585\u20131589.","journal-title":"JAMA"},{"key":"60_CR75","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1007\/BF02064986","volume":"40","author":"J Zighelboim","year":"1995","unstructured":"Zighelboim J, Talley NJ, Phillips SF, et al.: Visceral perception in irritable bowel syndrome. Rectal and gastric responses to distension and serotonin type 3 antagonism. Dig Dis Sci 1995, 40:819\u2013827.","journal-title":"Dig Dis Sci"},{"key":"60_CR76","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1136\/gut.44.5.682","volume":"44","author":"EP Bouras","year":"1999","unstructured":"Bouras EP, Camilleri M, Burton DD, McKinzie S: Selective stimulation of colonic transit by the benzofuran 5-HT4 agonist, prucalopride, in healthy humans. Gut 1999, 44:682\u2013686.","journal-title":"Gut"},{"key":"60_CR77","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0016-5085(00)70251-4","volume":"118","author":"CM Prather","year":"2000","unstructured":"Prather CM, Camilleri M, Zinmeister AR, et al.: Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000, 118:463\u2013468.","journal-title":"Gastroenterology"}],"container-title":["Current Treatment Options in Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-001-0060-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11938-001-0060-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11938-001-0060-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T22:01:43Z","timestamp":1737064903000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11938-001-0060-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8]]},"references-count":77,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8]]}},"alternative-id":["60"],"URL":"https:\/\/doi.org\/10.1007\/s11938-001-0060-0","relation":{},"ISSN":["1092-8472","1534-309X"],"issn-type":[{"type":"print","value":"1092-8472"},{"type":"electronic","value":"1534-309X"}],"subject":[],"published":{"date-parts":[[2001,8]]}}}